Skip to main
RADX
RADX logo

RADX P/E Ratio

P/E Ratio as of Jul 1, 2025: -0.35

Average-0.3948
Median-0.3900
Minimum-0.4400
Maximum-0.3500
-0.35
Past Month+0.03 (7.89%)
The P/E ratio for RADX is -0.35 as of Jul 1, 2025. This represents a increase of 84.21% compared to its 12-month average P/E ratio of -0.19. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.

Radiopharm Theranostics Ltd P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)

Radiopharm Theranostics Ltd’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Radiopharm Theranostics Ltd to industry peers.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

RADX P/E Ratio Historic Data

DateStock priceP/E ratio
Jul 1, 2025$4.287-0.35
Jun 2, 2025$5.169-0.42
May 1, 2025$4.00-0.33
Apr 1, 2025$4.68-0.38
Mar 3, 2025$5.50-0.45
Feb 3, 2025$4.43-0.18
Jan 14, 2025$5.40-0.22

RADX End of Year P/E Ratio

DateP/E ratioChange
2025-0.35

FAQs About Radiopharm Theranostics Ltd (RADX) P/E ratio

The latest P/E ratio of RADX is -0.35, as of Jul 1, 2025. This is calculated based on its current stock price and earnings per share (EPS).

Radiopharm Theranostics Ltd’s last 12-month average P/E ratio is -0.19, compared to its current P/E ratio of -0.35. This reflects a increase of 84.21%.

Radiopharm Theranostics Ltd’s current P/E ratio of -0.35 is higher than its last 12-month average P/E of -0.19. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.

Radiopharm Theranostics Ltd’s average P/E ratio over the last 3 years is -0.06. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.

Radiopharm Theranostics Ltd’s average P/E ratio over the last 5 years is -0.04. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.

Radiopharm Theranostics Ltd (RADX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.